Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | STAMPEDE trial: QoL data in prostate cancer

Hannah Rush,MBChB, MRC Clinical Trials Unit, University College London, London, UK, discusses the comparative quality of life (QoL) data in metastatic prostate cancer patients randomized to docetaxel or abiraterone in the STAMPEDE trial (NCT00268476). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.